General form of registration statement for all companies including face-amount certificate companies

Consolidated Statement of Cash Flows (OWP Ventures, Inc.)

v3.19.2
Consolidated Statement of Cash Flows (OWP Ventures, Inc.) - USD ($)
6 Months Ended 9 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Dec. 31, 2018
Cash flows from operating activities      
Net loss $ (2,648,744) $ (1,960,083)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization expense 5,005    
Debt discount amortization 125,000    
Decrease (increase) in assets:      
Other current assets 110,741    
Increase (decrease) in liabilities:      
Accounts payable 53,935    
Accrued expenses 66,079    
Net cash used in operating activities (1,933,479)    
Cash flows from investing activities      
Purchase of fixed assets (366,585)    
Net cash used in investing activities (366,585)    
Cash flows from financing activities      
Proceeds from convertible note payable 500,000    
Proceeds from advances from shareholders    
Proceeds from sale of common stock 1,950,000    
Net cash provided by financing activities 2,243,602    
Effect of exchange rate changes on cash 143,001    
Net increase (decrease) in cash 86,539    
Cash - beginning 125,846    
Cash - ending 212,385 125,846 $ 125,846
Supplemental disclosures:      
Interest paid 14,965    
Income taxes paid    
Non-cash financing transactions:      
Beneficial conversion feature 125,000    
OWP Ventures, Inc. [Member]      
Cash flows from operating activities      
Net loss     (1,959,982)
Minority interest in net loss     (101)
Adjustments to reconcile net loss to net cash used in operating activities:      
Bad debts expense     50,000
Depreciation and amortization expense     1,961
Debt discount amortization     75,000
Stock issued for services     285,600
Decrease (increase) in assets:      
Other current assets     131,488
Increase (decrease) in liabilities:      
Accounts payable     123,870
Accrued expenses     23,667
Net cash used in operating activities     (1,268,497)
Cash flows from investing activities      
Cash acquired in One World Pharma, Inc. investment     4,739
Investment in note receivable     (50,000)
Investment in One World Pharma, Inc.     (350,000)
Purchase of fixed assets     (358,400)
Net cash used in investing activities     (753,661)
Cash flows from financing activities      
Proceeds from convertible note payable     300,000
Proceeds from advances from shareholders     514,141
Proceeds from notes payable     200,000
Proceeds from contributed capital     136,440
Proceeds from sale of common stock     1,001,513
Net cash provided by financing activities     2,152,094
Effect of exchange rate changes on cash     (4,090)
Net increase (decrease) in cash     125,846
Cash - beginning $ 125,846    
Cash - ending   $ 125,846 125,846
Supplemental disclosures:      
Interest paid     310
Income taxes paid    
Non-cash financing transactions:      
Beneficial conversion feature     $ 75,000